Trial · NCT07911410
Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy
NCT07911410, Recruiting, Qilu Hospital of Shandong University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy. Trials, record NCT07911410. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911410
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy
- NCT number
- NCT07911410
- Status
- Recruiting
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Qilu Hospital of Shandong University
- Conditions
- Painful Diabetic Peripheral Neuropathy, Diabetes Complication
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Toronto Clinical Scoring System (TCSS) total score from baseline to 3 months after surgery | 3 months after surgery | Change in total score of the Toronto Clinical Scoring System (TCSS) measured at 3 months after surgery relative to baseline. Full scale name: Toronto Clinical Scoring System Scale range: Minimum score = 0, Maximum score = 19 Interpretation: Higher total score indicates more severe diabetic peripheral neuropathy. Lower total score indicates less severe neuropathy. |
| Secondary | Plantar Temperature | Postoperative day 1 | Bilateral plantar temperature measured before PNS activation on postoperative day 1. |
| Secondary | Percentage Change in Neuropathic Symptom Score at Postoperative Day 1 | Postoperative day 1 | Percentage change in neuropathic symptom score assessed one day after surgery relative to baseline. |
| Secondary | Stable Minimum Bilateral Plantar Temperature After One-week PNS Stimulation | One week after PNS stimulation (before electrode removal) | The minimum stable bilateral plantar temperature recorded before electrode removal after one week of peripheral nerve stimulation. |
| Secondary | Percentage Change in Diabetic Neuropathic Symptom Score Before Electrode Removal | One week after PNS stimulation | Percentage change in diabetic neuropathic symptom score assessed before electrode removal after one week of continuous PNS stimulation, relative to baseline. |
| Secondary | Diabetic Foot Risk Status at 3 Months Postoperatively | 3 months after operation | Comprehensive assessment of diabetic foot risk indicators at 3 months after surgery. |
| Secondary | Change in Lower Limb Nerve Conduction Velocity Measured by Electromyography at 3 Months Postoperatively | 3 months after operation | Change in lower limb nerve conduction velocity detected by electromyography at 3 months after surgery. |
| Secondary | Status of Neurotrophic Agent Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of neurotrophic drugs at 3 months after surgery. |
| Secondary | Status of Hypoglycemic Agent Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of hypoglycemic agents at 3 months after surgery. |
| Secondary | Status of Analgesic Medication Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of analgesic medications at 3 months after surgery. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers12
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911410
GET https://conductscience.org/api/trials/v1/NCT07911410/registered